Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Lexapro

Who tops the pharma list?

Chris Ross, with the help of healthcare analysts GlobalData, takes a New Year look at the past, present and future of global pharma, and asks: what’s trending? 

- PMLiVE

AZ’s Soriot upbeat on firm’s prospects

Says pharma company can return to growth by 2017

- PMLiVE

The adaptation puzzle – change management

With so many attempts failing, isn’t it time you restructured your approach to change management?

- PMLiVE

Lundbeck names SVP for business development and HR

Jacob Tolstrup is promoted at Danish pharma company

- PMLiVE

Forest Labs slashes staff and bolsters product portfolio

New CEO Brenton Saunders makes his mark with restructure plans

Novartis building

Novartis offloads diagnostics unit to Grifols for $1.7bn

Part of strategy to focus on more profitable businesses

- PMLiVE

Ariad cuts 160 jobs in US after Iclusig suspension

Feels effect of FDA decision to suspend cancer drug on safety concerns

Shire Basingstoke

Shire mulls UK job cuts

Enters “employee consultation process” for research site in Basingstoke

- PMLiVE

Profits down at Lundbeck as revenues slip

Company still feeling effects of Lexapro patent loss

- PMLiVE

Novartis debates future of Horsham site

UK research centre could close

- PMLiVE

Incivek decline forces Vertex job cuts

370 positions to be axed

- PMLiVE

EMA backs Lundbeck’s Brintellix in depression

Drug recommended for approval to treat major depressive episodes in adults

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links